niclosamide has been researched along with Dermatitis, Atopic in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weiss, A | 1 |
| Delavenne, E | 1 |
| Matias, C | 1 |
| Lagler, H | 1 |
| Simon, D | 1 |
| Li, P | 1 |
| Hansen, JU | 1 |
| Dos Santos, TP | 1 |
| Jana, B | 1 |
| Priemel, P | 1 |
| Bangert, C | 1 |
| Bauer, M | 1 |
| Eberl, S | 1 |
| Nussbaumer-Pröll, A | 1 |
| Anne Österreicher, Z | 1 |
| Matzneller, P | 1 |
| Quint, T | 1 |
| Weber, M | 1 |
| Nielsen, HM | 1 |
| Rades, T | 1 |
| Johansen, HK | 1 |
| Westh, H | 1 |
| Kim, W | 1 |
| Mylonakis, E | 1 |
| Friis, C | 1 |
| Guardabassi, L | 1 |
| Pace, J | 1 |
| Lundberg, CV | 1 |
| M'Zali, F | 1 |
| Butty, P | 1 |
| Sørensen, N | 1 |
| Nielsen, HB | 1 |
| Toft-Kehler, R | 1 |
| Guttman-Yassky, E | 1 |
| Stingl, G | 1 |
| Zeitlinger, M | 1 |
| Sommer, M | 1 |
1 trial available for niclosamide and Dermatitis, Atopic
| Article | Year |
|---|---|
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.
Topics: Animals; Anti-Bacterial Agents; Dermatitis, Atopic; Humans; Methicillin-Resistant Staphylococcus aur | 2022 |